IDERA PHARMACEUTICALS, INC. Insider Trading for January 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in IDERA PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in IDERA PHARMACEUTICALS, INC. for January 2021.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 12 2021 | IDRA | IDERA PHARMACEUTIC ... | Kirby John J. | Chief Financial Off ... | Option Exercise | A | 4.28 | 51,000 | 218,280 | 51,000 | |
Jan 12 2021 | IDRA | IDERA PHARMACEUTIC ... | Kirby John J. | Chief Financial Off ... | Sell | S | 4.22 | 1,693 | 7,152 | 33,882 | 35.6 K to 33.9 K (-4.76 %) |
Jan 12 2021 | IDRA | IDERA PHARMACEUTIC ... | Tarka Elizabeth Ann | Chief Medical Offic ... | Option Exercise | A | 4.28 | 51,000 | 218,280 | 51,000 | |
Jan 12 2021 | IDRA | IDERA PHARMACEUTIC ... | Tarka Elizabeth Ann | Chief Medical Offic ... | Sell | S | 4.19 | 1,745 | 7,310 | 18,255 | 20 K to 18.3 K (-8.72 %) |
Jan 12 2021 | IDRA | IDERA PHARMACEUTIC ... | Lim Bryant David | SVP and General Cou ... | Option Exercise | A | 4.28 | 51,000 | 218,280 | 51,000 | |
Jan 12 2021 | IDRA | IDERA PHARMACEUTIC ... | Lim Bryant David | SVP and General Cou ... | Sell | S | 4.21 | 1,711 | 7,202 | 38,064 | 39.8 K to 38.1 K (-4.30 %) |
Jan 12 2021 | IDRA | IDERA PHARMACEUTIC ... | MILANO VINCENT | President & CEO | Option Exercise | A | 4.28 | 95,000 | 406,600 | 95,000 | |
Jan 12 2021 | IDRA | IDERA PHARMACEUTIC ... | MILANO VINCENT | President & CEO | Sell | S | 4.20 | 3,210 | 13,474 | 208,611 | 211.8 K to 208.6 K (-1.52 %) |
Jan 11 2021 | IDRA | IDERA PHARMACEUTIC ... | Lim Bryant David | SVP and General Cou ... | Sell | S | 3.91 | 1,465 | 5,722 | 39,775 | 41.2 K to 39.8 K (-3.55 %) |
Jan 11 2021 | IDRA | IDERA PHARMACEUTIC ... | MILANO VINCENT | President & CEO | Sell | S | 3.91 | 2,740 | 10,700 | 211,821 | 214.6 K to 211.8 K (-1.28 %) |
Jan 06 2021 | IDRA | IDERA PHARMACEUTIC ... | Kirby John J. | Chief Financial Off ... | Sell | S | 3.90 | 862 | 3,362 | 35,575 | 36.4 K to 35.6 K (-2.37 %) |
Jan 06 2021 | IDRA | IDERA PHARMACEUTIC ... | SCHAFER CAROL | Director | Grant | A | 4.02 | 3,620 | 14,552 | 48,488 | 44.9 K to 48.5 K (+8.07 %) |
Jan 06 2021 | IDRA | IDERA PHARMACEUTIC ... | Goldberg Mark Alan | Director | Grant | A | 4.02 | 3,452 | 13,877 | 38,099 | 34.6 K to 38.1 K (+9.96 %) |
Jan 06 2021 | IDRA | IDERA PHARMACEUTIC ... | GERAGHTY JAMES A | Director | Grant | A | 4.02 | 4,851 | 19,501 | 104,770 | 99.9 K to 104.8 K (+4.85 %) |
Jan 06 2021 | IDRA | IDERA PHARMACEUTIC ... | DOUGHERTY MICHAEL R | Director | Grant | A | 4.02 | 3,515 | 14,130 | 37,645 | 34.1 K to 37.6 K (+10.30 %) |
Jan 05 2021 | IDRA | IDERA PHARMACEUTIC ... | SOLAND DANIEL B | Chief Operating Off ... | Option Exercise | A | 4.02 | 200,000 | 804,000 | 200,000 | |
Jan 05 2021 | IDRA | IDERA PHARMACEUTIC ... | SOLAND DANIEL B | Chief Operating Off ... | Option Exercise | A | 4.02 | 200,000 | 804,000 | 200,000 |